HOME >> BIOLOGY >> NEWS
Animal studies show promise treating severe chronic pain

Researchers may be on the trail of a new and more targeted treatment for severe chronic pain. In the current issue of the Journal of Clinical Investigation, a team of scientists established in a series of animal studies the therapeutic potential of selectively deleting specific nerve cells from the nervous system that convey severe chronic pain.

So effective was the treatment in eight dogs severely affected by osteroarthritis, cancer-related pain, or both, all eventually became more active and later walked with slight or no limps. Just as importantly, none showed any adverse side effects from the treatment, their temperaments were improved, and their need for other pain-controlling medications was eliminated or greatly reduced.

The authors also reported selectively deleting the nerve cells, called C-fiber neurons, from among various human neurons cultured together in the laboratory, an indication the strategy might work in people. C-fibers convey to the central nervous system sensations of noxious heat and certain inflammatory signals. "Some have referred to the technique as using a 'molecular scalpel,'" said Dr. Michael J. Iadarola, a scientist at the NIH's National Institute of Dental and Craniofacial Research (NIDCR) and a senior author on the paper. "The technique selectively deletes certain neurons but leaves others untouched. As a result, the nervous system functions normally, it's just a certain spectrum of pain responsiveness that has been deleted."

Currently, doctors have no way of selectively eliminating nerve cells involved in chronic pain. Opioid-based analgesics, the mainstay of current treatments for moderate to severe chronic pain, cannot provide universal relief, and other treatments are nonselective and/or can cause serious side effects.

Iadarola said this month's paper stems from using the old drug resiniferatoxin, or RTX, in a new way. First isolated in the 1970s, RTX is often used as a laboratory tool b
'"/>

Contact: Bob Kuska
kuskar@nidcr.nih.gov
301-594-7560
NIH/National Institute of Dental and Craniofacial Research
3-May-2004


Page: 1 2 3 4

Related biology news :

1. Animal research suggests plant estrogens in soy do not increase breast cancer risk
2. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
3. UF researcher: Animals think in their own way, but unlike humans
4. Animal studies show CA4P suppresses development and induces regression of ocular neovascularization
5. Animal study demonstrates carbon monoxide may help heart patients
6. Animals can be induced to cooperate if partners reciprocate and benefits accumulate
7. Animal study finds embryonic stem cells can repair heart muscle
8. Animal welfare can now be objectively measured
9. Animals regulate their numbers by own population density
10. UF researchers score gene therapy advance: Animal study shows high blood pressure prevented in future generations
11. Experimental Staph Vaccine Broadly Protective In Animal Studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... 13, 2019 , ... BioMedGPS is excited to host its ... event at Gothenburg’s Universeum Aquarium. Guests will be treated to an aquarium tour, ... Care. , SmartTRAK’s Advanced Wound Care Experts will serve as panelists. Susan Paquette ...
(Date:5/8/2019)... FRANCISCO (PRWEB) , ... May 08, 2019 , ... ... (CRO) – has successfully leveraged the support services provided by Medrio , ... execute a clinical trial sponsor agreement. , By collaborating to position high-quality ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... is pleased to announce that Gunes Bender, Ph.D., a registered patent agent, ... practice group. In his new role, Bender provides technical support and scientific expertise ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... 2019 , ... Fulcrum Biometrics , a leading provider ... Pacific (BSP), the largest regionally owned bank in the South Pacific, selected Fulcrum ... deliver a fingerprint-based Know Your Customer (KYC) banking solution that is being rolled ...
(Date:4/10/2019)... Md. (PRWEB) , ... April ... ... GenCure, both regenerative medicine manufacturing technology leaders, have locked into multiple agreements ... ever before. Companies across the regenerative medicine industry, ranging from synthetic biology ...
(Date:4/9/2019)... ... ... Sonny Bar Lisa, or Sonny for short, is a quarter horse that was ... of diagnostics, an MRI was performed which revealed Sonny had torn his left front ... VetStem Regenerative Cell Therapy may be a treatment option for her horse ...
(Date:4/8/2019)... FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... accredited investors a $15 million preferred equity investment in the privately held pharmaceutical company, ... Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ...
Breaking Biology Technology:
Cached News: